bioAffinity Technologies, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BIAF Nasdaq 2836 bioaffinitytech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for bioAffinity Technologies, Inc.

bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD - Jul 22nd, 2026 6:08 am
BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell? - Jul 9th, 2026 11:34 am
bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues - Jul 7th, 2026 6:46 am
Q2 Virtual Investor Summit Presentations Now Available On Demand - Jun 30th, 2026 11:20 am
Q2 Investor Summit Virtual Live Wednesday June 24 - Jun 23rd, 2026 1:40 pm
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells - Jun 22nd, 2026 6:00 am
WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering - Jun 18th, 2026 12:15 pm
bioAffinity Technologies Announces Closing of $3.2 Million Offering - Jun 18th, 2026 11:16 am
WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering - Jun 17th, 2026 8:40 am
bioAffinity Technologies Announces Pricing of $3.2 Million Offering - Jun 17th, 2026 7:25 am
bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans - Jun 16th, 2026 6:06 am
Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar - Jun 2nd, 2026 6:00 am
BIAF Stock Slips Post Q1 Earnings Despite Strength in CyPath Lung - May 14th, 2026 8:27 am
bioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally? - Apr 16th, 2026 7:55 am
BC-Most Active Stocks - Mar 23rd, 2026 8:30 am
BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now? - Mar 5th, 2026 9:51 am
BIAF Stock Dips After Q3 Earnings Reflect Lower Sales and Wider Loss - Nov 19th, 2025 9:33 am
WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules - Oct 9th, 2025 12:00 pm
WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules - Oct 8th, 2025 2:15 pm
WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m - Sep 30th, 2025 10:30 am